Easy Access to Tirzepatide Online

Only $99 / first 6 weeks
Delivers the same active component as popular alternatives
  • All-in-one package: provider visit, medication, and shipping
  • Insurance-free access
  • No unclear billing or unexpected costs

Hear directly from our customers

Rachel S.
Rachel S.
★★★★★
Read More
My appetite dropped quickly after starting Tirzepatide. It’s easier to eat healthy, and I’ve already lost weight without struggling.
Olivia B.
Olivia B.
★★★★★
Read More
I was skeptical at first, but Tirzepatide truly works. I’ve lost weight steadily, and my energy levels have drastically improved.
Megan D.
Megan D.
★★★★★
Read More
This is the first treatment that actually worked for me. I’m losing weight consistently and finally keeping it off for good.
Lauren C.
Lauren C.
★★★★★
Read More
My doctor recommended Tirzepatide for weight loss and diabetes management. It’s working wonders, and I’m feeling healthier every week.
Natalie K.
Natalie K.
★★★★★
Read More
Within a few weeks on Tirzepatide, my appetite changed completely. I’m eating smaller portions and finally seeing real, lasting results.
Previous
Next

What is Tirzepatide?

Tirzepatide works by activating two hormone receptors involved in appetite and glucose control.

It helps balance metabolism, making it a powerful tool for managing diabetes and reducing weight.

How It Works:

  • Increases insulin when glucose rises
  • Decreases glucagon post-meal
  • Slows how fast your stomach empties
  • Improves insulin performance

Common Uses:

  • Treating Type 2 Diabetes
  • Supporting weight loss in overweight individuals

Used alongside a healthy lifestyle, Tirzepatide may help you reach better metabolic balance.

Pricing​

 Our Tirzepatide program is more than medication — it’s complete support for long-term health and weight management.

One Program, Many Benefits

What’s Included:
✔ 6 Weeks of Tirzepatide: One price covers all
✔ Telehealth Consultations: Speak with real medical professionals
✔ Meal Coaching: Develop healthier routines with expert input
✔ Biannual Labs: Track your metabolic health
✔ At-Home Kit: Supplies for easy injections
✔ Digital Resources: Stay on track with educational tools

$99 / 6 week plan

Target and lose 15% of body weight in one year — naturally

Tirzepatide supports effective weight loss, with clinical research showing up to 15% body weight reduction in 12 months. For best results, combine treatment with a nutritious diet and steady exercise.

Dosages

Units to Milligrams

Units correspond to the volume drawn into the syringe, while milligrams specify the dose prescribed weekly. The quantity of units changes depending on Tirzepatide vial strength.

2 mg
Volume (units) Dose (mg) Price per month
10 Units 0.25 mg
20 Units 0.5 mg
30 Units 0.75 mg
40 Units 1.0 mg
50 Units 1.25 mg
5 mg / 1 ml
Volume (units) Dose (mg) Price per month
5 Units 0.25 mg
10 Units 0.5 mg
15 Units 0.75 mg
20 Units 1.0 mg
25 Units 1.25 mg

Begin Losing Weight Today in Just 4 Easy Steps

  • Medical Intake: Share your health background and weight loss goals.
  • Lab Tests: Complete metabolic evaluation for safety and precision.
  • Virtual Consultation: Speak with a licensed medical expert.
  • Medication Delivered: Prescription shipped directly to your door.

FAQ

What is Tirzepatide?

Tirzepatide is a once-weekly injectable medication that activates two gut hormone receptors, GIP and GLP-1. These actions help reduce appetite, slow digestion, improve blood sugar control, and promote significant weight loss when combined with healthy lifestyle changes.

 Unopened pens should be refrigerated at 36°F–46°F (2°C–8°C). After first use, they can be stored at room temperature (up to 86°F/30°C) for 21 days, away from direct heat or sunlight.

 While not required, a balanced, reduced-calorie diet and regular physical activity greatly improve results. Your healthcare provider may suggest a personalized plan for the best outcome.

 It works by reducing hunger signals, slowing stomach emptying, and enhancing the body’s natural insulin response. This leads to lower calorie intake, better blood sugar regulation, and gradual, sustainable weight loss over time.

 Studies suggest it is safe for long-term use under medical supervision, but ongoing monitoring is important to track results and manage any side effects.

 It may be prescribed for adults with obesity, overweight with weight-related health conditions, or type 2 diabetes. A healthcare provider will determine eligibility based on your medical history and lab results.

 Some people notice reduced appetite and more stable blood sugar levels within 1–2 weeks. Meaningful weight loss is typically seen after 8–12 weeks of consistent use.

 It’s injected subcutaneously (under the skin) once a week, on the same day each week. You can inject it in your abdomen, thigh, or upper arm.

 It is not suitable for people with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN2), or severe allergic reactions to its ingredients.

 In some cases, yes. However, certain diabetes medications or drugs that affect blood sugar may require dose adjustments. Always discuss your medication list with your provider.

 Many people take it long-term to maintain weight loss and blood sugar control. Your provider will help decide the right duration based on your progress and health goals.

 The most common include mild nausea, upset stomach, constipation, diarrhea, and decreased appetite. These symptoms often lessen as your body adjusts to treatment.

Scroll to Top

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At AudeoTherapy, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.